The definitive guide to understanding the evolution of HCP engagement post COVID-19 and how to keep Life Sciences commercial teams relevant in the digital age
Life Sciences field teams have experienced a massive transition due to restricted access to healthcare professionals (HCPs). The new normal means limited in-person appointments and the need for more digital and omnichannel engagement. To make a real difference, the goal must be deeper understanding of providers that leads to higher quality relationships.
How the role of pharmaceutical representative, and Commercial Operations in Life Science companies is changing post-COVID 19
Trends explaining the decline in number of pharma reps
How the Sunshine Act hurts access to HCPs
Staying relevant with telehealth, omnichannel messaging and virtual collaboration
Best practices and tips for commercial teams to become successful
How digital assistants, digital messaging and collaboration tools can make real difference
